Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Repurchase of shares in Intrum AB (publ)

During the period 2 November 2020 until 6 November 2020, Intrum AB (publ) (“Intrum”) has repurchased a total of 125,000 shares as part of the buyback program introduced by the Board of Directors to secure the obligations of Intrum (including social security contributions) relating to the long-term incentive program 2020. As a result, the buyback program, which Intrum announced on 23 October 2020, is hereby completed since the maximum amount of shares (250,000) has been repurchased. The buyback program was carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 (“MAR”)

Mandatory notification of trade – primary insider

The following primary insider in Multiconsult ASA has sold shares in Multiconsult ASA: Torben Halland Wedervang, deputy board member (employee representative) Multiconsult ASA, has on 9 November 2020 sold 1 000 shares in Multiconsult ASA at an average price of NOK 121.00 per share and will after the transaction hold 2 314 shares in Multiconsult ASA.For further information, please contact:    Investor relations:      Pål-Sverre Jørgensen, Group Treasurer & Investor Relations Officer      Phone: +47 416 11 161      E-mail: ir@multiconsult.no    Media:      Gaute Christensen, VP

First patient enrolled in the phase I/II clinical trial testing FG001 in patients with high grade glioma

Copenhagen, Denmark, 9 November 2020 - FluoGuide A/S (“FluoGuide” or “the Company”) is pleased to inform that the first patient today was enrolled in the clinical trial testing safety and efficacy of FG001 in guiding high grade glioma surgery.FluoGuide’s phase I/II clinical trial, testing FG001 in patients with high grade glioma consists of two phases; (1) a dose escalation phase to establish safety and proof-of-concept, and (2) an efficacy assessment phase. The total number of patients in the entire phase I/II trial will be up to 36 patients. FluoGuide is pleased to inform that the

Mandatory notification of trade – primary insider

The following primary insider in Multiconsult ASA has purchased shares in Multiconsult ASA: Grethe Bergly, CEO in Multiconsult ASA,has on 9 November 2020 purchased 1 000 shares in Multiconsult ASA at an average price of NOK 123.00 per share and will after the transaction hold 29 751 shares in Multiconsult ASA.For further information, please contact:    Investor relations:      Pål-Sverre Jørgensen, Group Treasurer & Investor Relations Officer      Phone: +47 416 11 161      E-mail: ir@multiconsult.no    Media:      Gaute Christensen, VP Communications      Phone: +47 911

Rabbalshede Kraft publishes EU-growth prospectus

The Board of Rabbalshede Kraft AB (publ) has prepared an EU growth prospectus regarding the forthcoming rights issue of the company's B shares. The prospectus has today, November 9, 2020, been approved and registered by the Swedish Financial Supervisory Authority.On November 5 2020, the Board of Rabbalshede Kraft claimed the authorization decided by the annual general meeting on April 28 2020, and decided that the company’s share capital shall increase by a maximum of SEK 142 298 795 through a new issue of a maximum of 28 459 759 Series B shares in the company. The Board’s decision is in

Brighter has qualified to the top 10 in the Healthtech Unicorn Battle Europe

Brighter was nominated to the Healthtech Unicorn Battle Europe and, as a result, has qualified as one of the carefully selected top rated companies that are given the opportunity to pitch their idea live in the contest. The submission relates primarily to Brighter’s pioneering diabetes offering, Actiste® Diabetes Management as a Service. “We are very proud to be one of the few selected companies. It confirms that Brighter is on the right track with our aim and mission, and we are ready to make an impact,” says Henrik Norström, CEO Brighter. Date and time: November 10, 2020, 3 pm CET.

Exercise of Mandatory Exchange Option

International Personal Finance plc (IPF) specialises in providing unsecured consumer credit to 1.7 million customers across 10 markets. IPF operates the world's largest home credit business and a successful fintech business, IPF Digital. INTERNATIONAL PERSONAL FINANCE PLC ANNOUNCES EXERCISE OF MANDATORY EXCHANGE OPTION INTERNATIONAL PERSONAL FINANCE PLC (incorporated with limited liability in England and Wales with registered number 06018973)(the "Issuer" or "IPF") EUR 412,000,000 5.75 per cent. Senior Unsecured Unsubordinated Fixed Rate Notes due 2021 (ISIN: XS1054714248) (

Alligator Bioscience presents at the SITC 35th Annual Meeting

Three projects showcased   -  ATOR-1015, ALG.APV-527 and Neo-X-Prime  -Lund, Sweden, November 9, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that it will present data from three immuno-oncology projects at the Society for Immunotherapy of Cancer’s (SITC) 35th Virtual Annual Meeting, November 9-14, 2020. The presentations will include the Phase I study of ATOR-1015, the Phase I-ready ALG.APV-527 developed in partnership with Aptevo Therapeutics, as well as the novel bispecific concept Neo-X-Prime. “The fact that three of our immuno-oncology projects have

Arcus ASA: Supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW.The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the

The Finnish Financial Supervisory Authority has approved a supplement to the prospectus prepared for the merger of Altia Plc and Arcus ASA

ALTIA PLC  STOCK EXCHANGE RELEASE  9 NOVEMBER 2020 AT 3:00 p.m. EET THIS STOCK EXCHANGE RELEASE MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW. The Finnish Financial Supervisory

TePe commits to climate action by setting a CO₂ neutrality goal

Committing to the UN Goals and the urgent need to take climate action, TePe has taken on the challenge of achieving carbon neutrality in products and packaging in 2022.‘Taking action to combat climate change and its impacts is one of the greatest challenges of our time. To tackle this challenge, we need to reduce our carbon emissions and move towards a fossil-free society. At TePe, we want to contribute to a positive development. Our CO₂ neutrality goal will be a catalyst for our sustainability initiatives and a step towards our overarching goal to become a CO₂ neutral company’, says Helena

The success of an omnichannel strategy thanks to UGC

As an expert in tailor-made blinds and curtains, Heytens has provided their customers with window decorations for more than 50 years. The brand started using Flowbox in early 2019, and has been consistently developing its communication objectives ever since. Implementing user-generated content (UGC) in their social media strategy strengthened their community and improved the customer journey. “At Heytens, we’re always looking to inspire with visual content allowing our clients to imagine what our products will look like in their own homes,” says Anaïs André, Digital Marketing Manager at

Stena Line moves to Stockholm Norvik Port

Ferry company Stena Line moves its Nynäshamn ferry terminal to the newly built Stockholm Norvik Port. On 9 November the terminal was officially opened with the first arrival of the vessel Stena Flavia at 7 a.m. The new ferry terminal is an important part of Stena Lines expansion plans in the Baltic Sea that includes the deployment of two new modern ferries and 30 % additional freight capacity on the Nynäshamn-Ventspils route in 2021.Stena line is one of the world’s leading ferry companies with 18 ferry routes in Europe. Three of them are operating across the Baltic Sea. Stena Line recently

Major shareholder announcement – Société Générale S.A.’s holding as at 4 November 2020

Vestas Wind Systems A/S, Aarhus, 9 November 2020Company announcement No. 39/2020   Major shareholder announcement – Société Générale S.A.’s holding as at 4 November 2020 Pursuant to Section 30 of the Danish Capital Markets Act, Vestas Wind Systems A/S hereby informs that the company has been notified on 9 November 2020 that Société Générale S.A, 29 Boulevard Haussmann, 75009 Paris, France, on 4 November 2020 had a holding of voting rights and share capital attached to the Vestas share corresponding to a position of 3.21 percent (previously 6.26 percent) of the total share capital

Stena Line moves to Stockholm Norvik Port

Ferry company Stena Line moves its Nynäshamn ferry terminal to the newly built Stockholm Norvik Port. On November 9th the terminal was officially opened with the first arrival of the vessel Stena Flavia at 7 a.m. The new ferry terminal is an important part of Stena Lines expansion plans in the Baltic Sea that includes the deployment of two new modern ferries and 30 % additional freight capacity on the Nynäshamn-Ventspils route in 2021.Stena Line is one of the world’s leading ferry companies with 18 ferry routes in Europe. Three of them are operating across the Baltic Sea. Stena Line

NextCell has formally kicked-off its Eurostars funded project ‘ Bioscale ’

NextCell Pharma AB (“NextCell” or the “Company”) announces today that it, in cooperation with the consortium members: MyCellHub, SEFA and Scinus Cell Expansion, now officially has kicked-off the earlier announced Eurostars project. The Eurostars project Bioscale will focus on using a novel cell expansion system developed by Scinus Cell Expansion, to further test, develop and validate the involved bioprocesses used in the production of NextCell’s drug candidate ProTrans™ (ProTrans).· NextCell has been granted €470,000 of a Eurostar grant totalling €1.6M. The total budget of the project is €2.

Neles strengthens its distributor network with 13 new partners in India, Sri Lanka, and Bangladesh

Neles Corporation’s press release on November 9, 2020, at 1:15 p.m. EETNeles signed 13 new distributor agreements in India, Sri Lanka, and Bangladesh in the second quarter of 2020. The new distributors help to further expand the coverage of Neles’ valve offering in the various customer industries of their respective countries. The agreements cover the following companies: · SureSales Automation Pvt Ltd (SAPL), Delhi · SB Enterprise, Kolkata · Fluidline Systems, Chennai · Equipment Fabricators & Traders (EFT), Chennai · Instrumech Engineers Pvt Ltd, Mumbai · Sunbeam

STONEHAVEN CONSULTING EXPANDS IN TERMS OF GEOGRAPHY AND PEOPLE

· Opening new office in Switzerland · Strengthening global team with new industry experts · Providing specialist life science consulting servicesStonehaven Consulting AG, a boutique consultancy firm supporting life sciences companies at various phases of development around the world, recently opened its new office in the greater Zurich area and expanded its office in London. As part of the ongoing strengthening of its global team, the company has also hired several people: · Rebeca Garcia Escudero, Analyst  · Katja Glauser, Analyst (

KVÆRNER ASA: UPDATE ON THE CONTEMPLATED MERGER WITH AKER SOLUTIONS ASA

CORRETION: Specification in approval date for merger.   NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. 9 November 2020 – Reference is made to the previous stock exchange announcements made by Kværner ASA (“Kvaerner”) regarding the contemplated merger with Aker Solutions ASA (“Aker

Brighter’s pioneering diabetes management solution Actiste® receives market approval in the United Arab Emirates

Brighter AB (publ) is proud to announce that its pioneering solution for improved diabetes management, Actiste®, has received market approval from the UAE Ministry of Health and Prevention (“MOHAP”). Some additional regulatory approvals for consumables included within the Actiste® Diabetes Management as a Service (“Actiste Service”) offering are still outstanding but underway. “The market approval in the UAE is a vital milestone allowing Brighter to start engaging with real-world patients and making a difference in their everyday life. We are glad to now be able to actively contribute to

Invitation to Noreco Third Quarter 2020 Earnings Call

Norwegian Energy Company ASA (“Noreco” or “the Company”) will publish its financial results for the third quarter 2020 on Wednesday 11 November 2020 at 07:00 (CET). A conference call, available as a webcast, will be hosted at 12:00 (CET).  To join webcast: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201111_8   ***  Contact:Cathrine Torgersen, EVP Investor Relations & CommunicationsPhone: +47 915 28 501Email: ct@noreco.com

HiQ provides support for InfoSolutions’ mobile Covid-19 testing

HiQ is assisting InfoSolutions with their assignment from the Public Health Agency of Sweden (Folkhälsomyndigheten) to increase national accessibility of testing for Covid-19. It involves PCR testing, which diagnoses active coronavirus infection.“This is the second project we’ve participated in that aims to reduce the impact of Covid-19 on the world. It’s nice to see that our broad knowledge in digitalising the healthcare sector and e-health will help control the pandemic,” says Helena Forsmark, Managing Director of HiQ Stockholm.HiQ’s assignment is to be the principal project manager

Buile Hill Academy awarded national Leading Parent Partnership Award

Salford, UK, 9[th] November 2020 – Salford-based Buile Hill Academy, part of the Consilium Academies Multi-Academy Trust, has been awarded the prestigious Leading Parent Partnership Award (LLPA) for its commitment to investing in parent and carer communications to ensure the success of pupils.Salford-based Buile Hill Academy, part of the Consilium Academies Multi-Academy Trust , has been awarded the prestigious Leading Parent Partnership Award (LLPA) for its commitment to investing in parent and carer communications to ensure the success of pupils.   The award,

There are no items matching the current filter
There are no more items matching the current filter
Back to top